Literature DB >> 3731377

Effect of menstrual cycle phase and exercise training on serum lipids.

N G Woods, T E Graham.   

Abstract

Studies of serum lipids in women training are inconclusive and have not considered menstrual hormones. Women (N = 8, 20-25 yrs) were studied over 3 consecutive cycles. The first cycle was a control cycle and then they trained for two cycles (3 times/wk for 30 min/day at 60% max HR reserve). Blood samples were drawn 5 to 7 days after the onset of menses (M) and mid-luteal (L) of all three cycles. Cycle phase (i.e. M vs L) did not influence total cholesterol or HDL cholesterol but triglyceride (TG) was higher (p less than 0.05) at M. The training period (65 +/- 7.5 days (SD) resulted in a significant (p less than 0.05) increase in VO2 max and decrease in resting HR. Training resulted in a decline (p less than 0.05) in HDL cholesterol from M1 to M2 (1.32 +/- 0.26 to 1.12 +/- 0.23 mmol/L) and a return to control by M3 (1.36 +/- 0.37 mmol/L). Training also resulted in TG declining (p less than 0.05) from L1 to L2 and from M2 to M3. Cycle phase only affected TG. Exercise training, however, resulted in a decline in TG and an initial decline in HDL cholesterol and a return to control levels during the second month of training.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731377

Source DB:  PubMed          Journal:  Can J Appl Sport Sci        ISSN: 0700-3978


  3 in total

1.  Variations in high-density lipoprotein subclasses during the menstrual cycle.

Authors:  P T Williams; M A Austin; R M Krauss
Journal:  Metabolism       Date:  1994-11       Impact factor: 8.694

Review 2.  Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis.

Authors:  J L Durstine; P W Grandjean; P G Davis; M A Ferguson; N L Alderson; K D DuBose
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Lipidomic analysis of plasma samples from women with polycystic ovary syndrome.

Authors:  Zeina Haoula; Srinivasarao Ravipati; Dov J Stekel; Catharine A Ortori; Charlie Hodgman; Clare Daykin; Nick Raine-Fenning; David A Barrett; William Atiomo
Journal:  Metabolomics       Date:  2014-08-17       Impact factor: 4.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.